Cardiovascular Diseases

Richard Lee, MD

Richard Lee, MD

Harvard Department of Stem Cell and Regenerative Biology
Brigham and Women's Hospital
Harvard Medical School

The Lee Laboratory uses biotechnologies to discover and design new approaches to cardiovascular and metabolic diseases. We work at this interface using a broad variety of techniques in genomics, stem cell biology, and molecular biology.

Ronglih Liao, PhD

Ronglih Liao, PhD

Brigham and Women's Hospital
Harvard Medical School

Following tissue injury or genetic alteration, the heart undergoes a process of molecular and structural remodeling, ultimately resulting in cardiac dysfunction. The central focus of our laboratory’s research is to

Calum MacRae, MD, PhD

Calum MacRae, MD, PhD

Brigham and Women's Hospital
Harvard Medical School

Our lab is interested in the role of functional inputs such as mechanical forces, metabolism or electrical activity in refining the basic programs of cell specification and differentiation in cardiovascular development, disease, repair and regeneration.

Harald C. Ott, MD

Harald C. Ott, MD

Massachusetts General Hospital
Harvard Medical School

Dr. Harald C. Ott is a fellow in cardiothoracic surgery at the Massachusetts General Hospital and an Instructor in Surgery at the Harvard Medical School.

Kevin Kit Parker, PhD

Kevin Kit Parker, PhD

Harvard School of Engineering and Applied Sciences
Wyss Institute for Biologically Inspired Engineering

My research team's focus is on understanding cellular mechanotransduction in the heart.

William T. Pu, MD

William T. Pu, MD

Boston Children's Hospital
Harvard Medical School

Goals of Dr. Pu's research include:
1. To understand the transcriptional network regulating heart development and disease
2. To understand cell lineage specification in heart development and regeneration
3. To understand genetic contributions to congenital heart disease.